Metraipolis › archive › dc_501030db69b8

Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors — Europe PMC PMID:41516330

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41516330
DOI
10.3390/ijms27010458
License (as archived)
solo-consultazione
Archived
2026-11-07T05:44:14.996Z
SHA-256 of the archived text
c6a10c4283ff97d18031de3b535297110ef83fcda8e9624a22a0ffdaeceebbf7
Stable URL of this page
https://metraipolis.com/documento/dc_501030db69b8

How to cite

Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors — Europe PMC PMID:41516330 — Europe PMC (en), https://europepmc.org/article/MED/41516330 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_501030db69b8 (Metraipolis archive dc_501030db69b8, sha256 c6a10c4283ff97d18031de3b535297110ef83fcda8e9624a22a0ffdaeceebbf7)
BibTeX
@misc{dc501030db69b8,
  title = {Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors — Europe PMC PMID:41516330},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41516330},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_501030db69b8; sha256 c6a10c4283ff97d18031de3b535297110ef83fcda8e9624a22a0ffdaeceebbf7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41516330. Agents can read the archived copy with the MCP tool read_document.